[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100561197":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":38,"responsibleParty":54,"collaborators":10,"id":56,"slug":10,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Peking University Third Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"group 1",null,"Group 1(small target delineation)：The target bolume only includes local tumor.",[13],"Radiation: Target volume delineation",{"label":15,"type":10,"description":16,"interventionNames":17},"group 2","Group 2(small target delineation)：The target bolume includes local tumor and adjacent vertebral area.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"RADIATION","Target volume delineation","Group 1(small target delineation)：The target bolume only includes local tumor. Group 2(small target delineation)：The target bolume includes local tumor and adjacent vertebral area.",[9,15],[25],{"name":26,"affiliation":5,"role":27},"Hongqing Zhuang","STUDY_DIRECTOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Hongqing Zhuang, Doctor","CONTACT","13051776232","hongqingzhuang@163.com",{"name":35,"role":31,"phone":36,"phoneExt":10,"email":37},"Yuxia Wang","15001292991","lily31415926@126.com",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist.","RECRUITING","Beijing","Beijing Municipality","100191","China",{"type":47,"coordinates":48},"Point",[49,50],116.39723,39.9075,{"lat":50,"lon":49},[53],{"name":26,"role":31,"phone":32,"phoneExt":10,"email":33},{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100561197",false,"NCT06587022","Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors","ST-SBRT","Inclusion Criteria:\n\n* Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy;\n* Patients with sufficent pre-treatment imaging data\n* Patients who can cooperate with imaging review and follow-up after radiotherapy.\n\nExclusion Criteria:\n\n* Patients with an expected survival of less than 3 months;\n* Patients with second-course radiotherapy;\n* Patients with physical conditions that cannot tolerate stereotactic radiotherapy;\n* Patients with extensive spinal metastasis and no local therapeutic value","ALL","18 Years","90 Years",{"count":66,"type":67},500,"ESTIMATED","OBSERVATIONAL","The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.",[71],"Spinal Tumor","2024-09-04",{"date":74,"type":75},"2024-09-19","ACTUAL",{"date":77,"type":75},"2017-01-01",{"date":79,"type":67},"2027-12-30",{"name":5,"class":6},1]